Cabaletta Bio Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Cabaletta Bio Stock Summary

Cabaletta Bio competes with Biomea Fusion, Stoke Therapeutics, Akero Therapeutics, Q32 Bio, and Gossamer Bio. Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Cabaletta Bio, Inc. was incorporated in 2017 and is headquartered in Philadelphia, Pennsylvania. Cabaletta Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 57 people.

Cabaletta Bio Key Financial Ratios

Cabaletta Bio Key Balance Sheet Accounts

Cabaletta Bio Key Income Statement Accounts

Cabaletta Bio Key Cash Accounts

Cabaletta Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Cabaletta Bio's current stock value. Our valuation model uses many indicators to compare Cabaletta Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cabaletta Bio competition to find correlations between indicators driving Cabaletta Bio's intrinsic value. More Info.Cabaletta Bio is rated fourth in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Cabaletta Bio's Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cabaletta Bio's earnings, one of the primary drivers of an investment's value.

Cabaletta Bio Systematic Risk

Today, most investors in Cabaletta Bio Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Cabaletta Bio's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Cabaletta Bio growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Cabaletta Bio help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Cabaletta Bio. We use our internally-developed statistical techniques to arrive at the intrinsic value of Cabaletta Bio based on widely used predictive technical indicators. In general, we focus on analyzing Cabaletta Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Cabaletta Bio's daily price indicators and compare them against related drivers.

When running Cabaletta Bio's price analysis, check to measure Cabaletta Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cabaletta Bio is operating at the current time. Most of Cabaletta Bio's value examination focuses on studying past and present price action to predict the probability of Cabaletta Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cabaletta Bio's price. Additionally, you may evaluate how the addition of Cabaletta Bio to your portfolios can decrease your overall portfolio volatility.